Life Science Nation Newsletter | January 3, 2019 | Issue 298

  The LSN Story   |   Investor Platform   |   Company Platform   |   RESI Conference   |   Fundraising Consulting
   Life Science Investor Mandates
(Dec. 27 - Jan. 2 )
Seeks to Invest Broadly Across Life Sciences, with Strongest Interests in Novel Drug Delivery Systems
Invests Up to $25M in USA-Based Life Science Companies with High Growth Potential
Invests Up to $30M in Therapeutics and Diagnostics Opportunities in North America with a Strong China Angle
Invests in Therapeutics, Diagnostics, and Digital Health Technologies with Interests in Oncology, Immunology, and Diabetes
LSN Services
LSN Videos
LSN Media Partners

Created & Produced by